Davis Capital Management’s Medline Inc MDLN Stock Holding History

Davis Capital Management’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39	Buy	+1	New	+$40	﹤0.01%	1246

Other funds holding MDLN

Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Robeco Institutional Asset Management

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

Premier Fund Managers Guildford, United Kingdom $1.1B AUM 14.42% 1-Year Est. Return

Clio Asset Management Charlottesville, Virginia $126M AUM 16.01% 1-Year Est. Return

Fideuram Asset Management (Ireland) Dublin 1 $5.26B AUM

Pictet Bank & Trust Nassau, Bahamas $93.3M AUM 21% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Davis Capital Management's MDLN Position: Q2 2026 in Review

Davis Capital Management opened a new position in Medline Inc (MDLN) in Q2 2026: 1 share worth $39. The stake represents ﹤0.01% of the portfolio and ranks #1246 among its holdings.

59 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

Davis Capital Management held 1 share of Medline Inc worth $39 as of Q2 2026.
Medline Inc was a new Davis Capital Management position in Q2 2026.
Medline Inc made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #1246 holding.
59 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.